Why Trelagliptin cannot be taken casually and analysis of possible risks caused by abuse
Trelagliptin (Trelagliptin) is a long-acting DPP-4 inhibitor (Dipeptidyl Peptidase-4 inhibitor), mainly used to treat type 2 diabetes. Prolongs glucagon-like peptide-1 (GLP-1 by inhibiting DPP-4enzyme activity ) and glucose-dependent insulinotropicpeptide (GIP) action time, thereby promoting insulin secretion, inhibiting glucagon release, and improving blood sugar control. Since its mechanism of action is closely related to the function of pancreatic beta cells, the medication must be taken under the guidance of a doctor. Do not adjust the dosage or increase or decrease the frequency of medication at will.
Abuse or indiscriminate use of trolagliptin may lead to blood sugar fluctuations or the risk of hypoglycemia. Although the risk of hypoglycemia is relatively low when DPP-4 inhibitors are used alone, if used simultaneously with other antidiabetic drugs (such as sulfonylureas or insulin), random increases or frequent medication can significantly increase the probability of hypoglycemia events, causing dizziness, fatigue, palpitations, and even life-threatening conditions.

Long-term irregular use of trolagliptin may increase the burden on the pancreas, affect beta cell function, and may even lead to the risk of pancreatitis. In addition, abuse may also affect kidney and liver metabolism, especially in patients with renal insufficiency or abnormal liver function. Drug accumulation may increase toxic reactions, including indigestion, elevated liver enzymes, etc.
Trelagliptin should be taken Strictly follow the doctor's advice, follow the principle of once a day, fixed dose, and regularly monitor blood sugar, blood lipids, liver and kidney function, and weight changes. When symptoms of abnormal blood sugar, hypoglycemia or digestive tract discomfort occur, you should seek medical treatment in time and do not adjust the dosage yourself. Rational use can significantly improve blood sugar control and delay diabetic complications, but abuse or indiscriminate use of medications may cause serious health risks.
Reference link:https://www.drugs.com
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)